Showing results (61-70 of 15,193) with videos related to

Sort By:
Pageof 1,520
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 29, 2000
The influence of hyperthyroidism on the hypothalamic-pituitary-gonadal axisS Zähringer, A Tomova, K von Werder, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1996
The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonusB Reichardt, M Schrader, J Mojto, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1986
Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegalyM Losa, J Schopohl, A König, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 25, 2005
Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide (Lanreotide Autogel)B Gutt, M Bidlingmaier, K Kretschmar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 1994
Endovascular irradiation--a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary resultsH D Böttcher, B Schopohl, D Liermann, et al.
Klinische Padiatrie|March 23, 2013
Treatment of children with severe haemophilia A and inhibitors: a health economic evaluation for GermanyK Berger, D Schopohl, D Eheberg, et al.
European Journal of Endocrinology|June 24, 2006
Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegalyB Steffin, B Gutt, M Bidlingmaier, et al.
Klinische Wochenschrift|January 22, 1991
Long-term treatment with SMS 201-995 in resistant acromegaly: effectiveness of high doses and continuous subcutaneous infusionG Mehltretter, S Heinz, J Schopohl, et al.
Hamostaseologie|November 6, 2014
[Prophylactic factor substitution in severe haemophilia A. Economic assessment in adult patients]K Berger, D Schopohl, D Eheberg, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 21, 2016
Blood Product Supply in Germany: The Impact of Apheresis and Pooled Platelet ConcentratesKarin Berger, Dorothee Schopohl, Georg Wittmann, et al.
Pageof 1,520